Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26F9LQ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,840
Award facts
- Contract value 100% obligated
- $17,839.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corporation, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,839.70 by the Defense Logistics Agency on January 16, 2026, for the supply of Advair HFA 230-21 microgram inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by January 20, 2026, at the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc.
This award is issued under Cencora's substantial Indefinite Delivery Contract with Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. That comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The Defense Logistics Agency Medical Supply Chain utilizes this contract framework to efficiently fulfill essential pharmaceutical requirements for military treatment facilities and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9LQ9?
SPE2DR26F9LQ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LQ9 worth?
The government has obligated $17,840 on SPE2DR26F9LQ9.
Is contract SPE2DR26F9LQ9 an order under another contract?
Yes. SPE2DR26F9LQ9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LQ9 competed?
The extent of competition for SPE2DR26F9LQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award